Article Versions Notes

Cantoni D, Siracusano G, Mayora-Neto M, Pastori C, Fantoni T, Lytras S, Di Genova C, Hughes J, on behalf of the Ambulatorio Medico San Luca Villanuova Group, Lopalco L, et al. Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines. 2023; 11(1):58. https://doi.org/10.3390/vaccines11010058

Cantoni, Diego, Gabriel Siracusano, Martin Mayora-Neto, Claudia Pastori, Tobia Fantoni, Spyros Lytras, Cecilia Di Genova, Joseph Hughes, on behalf of the Ambulatorio Medico San Luca Villanuova Group, Lucia Lopalco, and et al. 2023. "Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms" Vaccines 11, no. 1: 58. https://doi.org/10.3390/vaccines11010058

Cantoni, D., Siracusano, G., Mayora-Neto, M., Pastori, C., Fantoni, T., Lytras, S., Di Genova, C., Hughes, J., on behalf of the Ambulatorio Medico San Luca Villanuova Group, Lopalco, L., & Temperton, N. (2023). Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms. Vaccines, 11(1), 58. https://doi.org/10.3390/vaccines11010058